1. PK/PD Core Facility, Department of Medicine; Roswell Park Cancer Institute; Buffalo; New York
2. Janssen Research & Development; LLC; Spring House; Pennsylvania
3. Drug Development Unit; Royal Marsden NHS Foundation Trust and The Institute of Cancer Research; Sutton; UK
4. START (South Texas Accelerated Research Therapeutics); San Antonio; Texas